Clinical Studies 14.1 Cardiovascular Outcomes Trial in Adult Patients with Cardiovascular Disease and Either Obesity or Overweight Overview of Clinical Trial Study 1 (NCT03574597) was a multi-national, multi-center, placebo-controlled, double-blind trial to determine the effect of WEGOVY injection relative to placebo on major adverse CV events (MACE) when added to current standard of care, which included management of CV risk factors and individualized healthy lifestyle counseling (including diet and physical activity) in adults with established CV disease and either obesity or overweight
It also contains essential vitamins, no added sugar and is formulated to keep consumers feeling satiated.
Aim for 2030 grams of protein at breakfast
Restore Retinol/Grapefruit (which contains an effective concentration of copper peptides that can be used very lightly once or twice
Ingredients Deionised Water, L-Carnitine, Malic Acid, Green Tea Extract, Natural Flavouring, Sweetener (Sucralose), Preservatives (Potassium Sorbate, Sodium Benzoate), Vitamin C (Ascorbic Acid)